Orphan drugs revisited: cost–effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma

from Informa Healthcare: Expert Review of Pharmacoeconomics & Outcomes Research: Table of Contents at http://bit.ly/1wN2fsM on October 29, 2014 at 01:49PM


Expert Review of Pharmacoeconomics & Outcomes Research, Ahead of Print.